This program enables pharmacists to stay current with the evolving landscape in the management of Hepatitis C. It includes a review of the disease, current treatment options, and agents in clinical development.

The Continuing Education Program reviews the allergist's approach to evaluating asthma, with a review of incidence/prevalence, pathophysiology, the allergic mechanism, and asthma triggers.

This Continuing Education Program reviews the current guidelines for the management and treatment of asthma in pediatric patients. Providing perspective on how to treat and monitor pediatric asthma.

This CE activity is designed to give clinicians a better understanding of the pharmacology, indications, contraindications, benefits/risk and clinical trials data of a broad spectrum of new agents and those that have been granted a new indication.

This program focuses on how ethics and the law intersect in the practice of pharmacy.

This program focuses on a number of aspects involving patient safety. One of the most discussed aspects of patient safety involves the concept of the safety culture within your organization.

This program is designed to give pharmacists information about the important role of prognostic and predictive biomarkers in healthcare as well as the applied clinical utility of biomarkers in both HIV and oncology.